Efficacy And Safety Of Combination Therapy For Treatment Of Overactive Bladder In Male Patients With Benign Prostatic Hyperplasia.
Condition(s):Overactive Bladder; Benign Prostatic HyperplasiaLast Updated:March 19, 2021Unknown status
Hide Studies Not Open or Pending
Condition(s):Overactive Bladder; Benign Prostatic HyperplasiaLast Updated:March 19, 2021Unknown status
Condition(s):Tamsulosin; Extracorporeal Shock Wave Lithotripsy; Stone, Kidney; Stone, Urinary; Pediatric DisorderLast Updated:March 10, 2023Active, not recruiting
Condition(s):Prostatic HyperplasiaLast Updated:September 19, 2014Completed
Condition(s):Urinary Retention PostoperativeLast Updated:February 15, 2024Not yet recruiting
Condition(s):Prostatic HyperplasiaLast Updated:September 19, 2014Completed
Condition(s):Overactive BladderLast Updated:January 7, 2016Completed
Condition(s):Benign Prostate HyperplasiaLast Updated:May 14, 2014Unknown status
Condition(s):BPHLast Updated:April 25, 2023Recruiting
Condition(s):Kidney StoneLast Updated:December 17, 2014Completed
Condition(s):Ischaemic Heart Disease (IHD); Benign Prostatic Hyperplasia (BPH); Lower Urinary Tract Symptoms (LUTS)Last Updated:February 27, 2019Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.